![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, July 28, 2020 6:42:38 PM
Mike Scott
Chief Operating Officer at Advent Bioservices & Visiting Professor, Anglia Ruskin University
1d • 1 day ago
Advent Bioservices is seeking a Validation Lead. If you have the experience and want to join a vibrant team as we build our business, please get in touch.
JOB VACANCY: Validation Lead
We are looking for a GMP experienced validation/qualification professional to progress their career with us in the exciting area of cell & gene therapies. With investment being made into the organisation and new build projects on the horizon, this is the ideal time to join the team and establish yourself as a key team member. As Validation Lead you will work across GMP manufacturing, Quality Control laboratory facilities and the Cryostorage facility to ensure that all aspects of validation comply with relevant regulations.
Job Summary
In this role, you will be supporting the validation of equipment, facilities, utilities and processes in accordance with GMP requirements. You will be preparing and maintaining validation plans, assisting systems owners with impact assessments and identifying validation requirements as well as the execution of validation protocols (equipment, facilities, utilities, computerised systems and processes). This will include cleanrooms, medical gas supply and computer systems including environmental monitoring-systems.
You will have the following experience/qualifications:
• A Degree (or equivalent) in a Science or related discipline
• Working knowledge of biopharmaceutical or pharmaceutical industry regulations and guidelines that relate to qualification/validation
• Demonstrable experience of validating manufacturing/laboratory equipment, facilities/utilities and processes
• Generation/execution of lifecycle documents (URS, DQ, IQ, OQ and PQ) in a biopharma, pharma or related industry
• Experience of computer validation systems is desirable.
We offer excellent opportunities for career progression along with training and the chance to be a part of a growing organisation. We also offer an attractive base salary and benefits package.
The candidate must have the right to work in the UK.
Interested candidates are encouraged to submit a CV and a supporting letter to recruitment@adventbio.uk
https://www.adventbio.uk/job-validation-lead-scientist
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM